Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 10-2013 | 12-2012 | 10-2012 | 12-2011 | |
| Sales | 0 | 340 | 0 | 16 | 16 |
| Cost of Goods | N/A | 131 | N/A | 5 | 5 |
| Gross Profit | N/A | 209 | 10 | 11 | 11 |
| Operating Expenses | 120 | 347 | 7 | 12 | 12 |
| Operating Income | -120 | -7 | -7 | 4 | 4 |
| Interest Expense | 0 | 2 | 0 | 0 | 0 |
| Other Income | 0 | 6 | 1 | 1 | 1 |
| Pre-tax Income | -120 | -4 | -6 | 5 | 5 |
| Net Income Continuous | -120 | -4 | -6 | 5 | 5 |
| Net Income | $-120 | $-4 | $5 | $5 | $5 |
| EPS Basic Total Ops | -5.00 | 0.00 | N/A | 0.00 | N/A |
| EPS Basic Continuous Ops | -3.87 | -0.30 | N/A | 0.54 | N/A |
| EPS Diluted Total Ops | -5.00 | 0.00 | N/A | 0.00 | N/A |
| EPS Diluted Continuous Ops | -3.87 | -0.30 | N/A | 0.54 | N/A |
| EBITDA(a) | $-120 | $4 | $-7 | $4 | $4 |